These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 1021012)

  • 1. Effect of a Rauscher leukemia virus vaccine upon chemical oncogenesis in the mouse.
    Basombrío MA; Pasqualini CD
    Arch Geschwulstforsch; 1976; 46(8):630-3. PubMed ID: 1021012
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Murine sarcoma virus pseudotypes used as immunogens against viral and chemical oncogenesis.
    Basombrío MA; Mayer AM; Pasqualini CD
    Cancer Res; 1977 Jun; 37(6):1768-76. PubMed ID: 192461
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of chemical carcinogenesis by viral vaccines.
    Whitmire CE; Huebner RJ
    Science; 1972 Jul; 177(4043):60-1. PubMed ID: 4339425
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An approach to C-type virus immunoprevention of spontaneously occurring tumors in laboratory mice.
    Kelloff GJ; Peters RL; Donahoe RM; Ghazzouli I; Sass B; Nims RM; Huebner RJ
    Cancer Res; 1976 Feb; 36(2 pt 2):622-30. PubMed ID: 175922
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immunoprophylaxis of transplantable methylcholanthrene-induced murine fibrosarcomas by immunization with embryo cells expressing endogenous murine leukemia virus antigens.
    Zbar B; Manohar V; Sugimoto T; Ashley MP; Kato Y; Rappaport P
    Cancer Res; 1981 Nov; 41(11 Pt 1):4499-507. PubMed ID: 6272979
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell-surface antigens induced by Friend and Rauscher virus complexes and their associated lymphatic leukemia viruses in the rat.
    Kuzumaki N; Kobayashi H
    Cancer Res; 1975 Jul; 35(7):1718-22. PubMed ID: 1131829
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative studies of purified subviral component vaccines and formalin-treated mammary tumor viruses from four inbred strains of mice.
    Girardi AJ; Dion AS; Pomenti AA; Holben JA
    J Natl Cancer Inst; 1985 Feb; 74(2):405-13. PubMed ID: 2983136
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunotherapy of a murine leukemia virus-infected, chemically induced murine sarcoma with antiviral antibodies.
    Ward EC; Iglehart JD; Weinhold KJ; Bolognesi DP
    J Natl Cancer Inst; 1982 Aug; 69(2):509-15. PubMed ID: 6955550
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virus-chemical carcinogenesis: a possible viral immunologic influence on 3-methylcholanthrene sarcoma induction.
    Whitmire CE
    J Natl Cancer Inst; 1973 Aug; 51(2):473-8. PubMed ID: 4358133
    [No Abstract]   [Full Text] [Related]  

  • 10. Vaccination of adult and newborn mice of a resistant strain (C57BL/6J) against challenge with leukemias induced by Moloney murine leukemia virus.
    Reif AE
    Cancer Res; 1985 Jan; 45(1):25-31. PubMed ID: 3965136
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Effect of vaccination of mice with endogenous retrovirus on the development of tumors induced by gamma-irradiation or 7,12-dimethylbenz[a]anthracene].
    Mazurenko NP; Iakovleva LS; Shcherbak NP; Pavlovskaia AI; Zueva IuN
    Eksp Onkol; 1987; 9(1):41-6. PubMed ID: 3028758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Experimental oncornavirus vaccines in the cat.
    Yohn DS; Olsen RG; Schaller JP; Hoover EA; Mathes LE; Heding L; Davis GW
    Cancer Res; 1976 Feb; 36(2 pt 2):646-51. PubMed ID: 943234
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protection of cats against progressive fibrosarcomas and persistent leukemia virus infection by vaccination with feline leukemia cells.
    Grant CK; de Noronha F; Tusch C; Michalek MT; McLane MF
    J Natl Cancer Inst; 1980 Dec; 65(6):1285-92. PubMed ID: 6253714
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The influence of N-(2-hydroxyethyl)-palmitamide on virus-induced sarcomas in chickens and Rauscher leukemia in mice.
    Svec P; Béderová E; Svec J
    Neoplasma; 1975; 22(5):519-24. PubMed ID: 1196434
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to murine leukemia virus gp70 and p15(E) in sera of BALB/c mice immunized with syngeneic chemically induced sarcomas.
    Klitzman JM; Brown JP; Hellström KE; Hellström I
    J Immunol; 1980 Jun; 124(6):2552-6. PubMed ID: 6246166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The immune response to Moloney murine leukemia virus-induced tumors: induction of cytolytic T lymphocytes specific for both viral and tumor-associated antigens.
    Flyer DC; Burakoff SJ; Faller DV
    J Immunol; 1986 Dec; 137(12):3968-72. PubMed ID: 3491152
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of antisera to interferon in studying oncogenic viruses.
    Inglot AD; Oleszak E
    Arch Immunol Ther Exp (Warsz); 1978; 26(1-6):529-36. PubMed ID: 219809
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of effective immunity to Moloney murine sarcoma virus using monoclonal anti-idiotypic antibody as immunogen.
    Powell TJ; Spann R; Nguyenduc M; Lamon EW
    J Immunol; 1989 Feb; 142(4):1318-24. PubMed ID: 2536772
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cross-reactive cellular and humoral immunity to carcinogen-induced chicken fibrosarcomas. II. Effect of prior immunization with transplantable tumors on primary tumor incidence.
    Edelman AS; Xue B; Galton JE; Sanchez P; Thorbecke GJ
    J Immunol; 1985 Sep; 135(3):2213-9. PubMed ID: 3926899
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor specific antigens in viral neoplasms and in unrelated virus infected tumors.
    Sjögren HO
    Ann Med Exp Biol Fenn; 1966; 44(2):227-31. PubMed ID: 4290659
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.